We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
10:30 - 11:30
K2
Breast cancer 1
Fatjona Kraja, Albania;
Orit Kaidar-Person, Israel
Poster Discussions
Clinical
10:30 - 11:30
Comparison of Radiation Dose to Cardiac Substructures in VMAT and 3DCRT for Post-Mastectomy Breast Cancer Patients
Kaniz Fatima , India
-4469
10:30 - 11:30
Final acute adverse events of hypofractionated adjuvant breast RT with VMAT and high dose simultaneous integrated boost: the DEBoRa phase II trial
Salvatore Minuti, Italy
-4955
10:30 - 11:30
Quality Indicators for Hypofractionated Breast Radiation Therapy: A international Delphi Consensus Study Endorsed by the ESTRO Breast Focus Group
Mouhamadou Bachir BA, France
-1741
10:30 - 11:30
QoL after ultra-hypofractionated whole breast irradiation in early-stage breast cancer: results from an Italian multi-centre observational study
Anna Giulia Becchetti, Italy
-2653
10:30 - 11:30
A future without surgery? Single-fraction preoperative radiotherapy with delayed or no surgery in low-risk breast cancer: The phase II SPORT-DNS trial
Tarek Hijal, Canada
-741
10:30 - 11:30
Breast cancer research potential of the new Swedish national quality registry for radiotherapy
Caroline Olsson, Sweden
-2300
10:30 - 11:30
Major Adverse Cardiac Events after breast radiotherapy: A 12-year multicentre cohort study with cardiac substructure NTCP modeling
Jeffrey Chun Hin Chan, China, Hong Kong Special Administrative Region
-861
10:30 - 11:30
CMR analysis of acute cardiotoxicity after HFRT with SIB radiotherapy in breast cancer with or without active breathing coordinator:a randomized study
Jun Yin, China
-1700
10:30 - 11:30
Real-World Evidence on Fractionation and Survival in Breast Cancer with an Indication for Nodal Irradiation
Irina Surovtsova, Germany
-2692
10:30 - 11:30
Retrospective multicenter study on adverse events of adjuvant radiotherapy in breast cancer patients treated with Trastuzumab Emtansine (T-DM1)
Edy Ippolito, Italy
-3449